Papers
Topics
Authors
Recent
Search
2000 character limit reached

Blockchain platform for COVID-19 vaccine supply management

Published 4 Jan 2021 in cs.DC | (2101.00983v1)

Abstract: In the context of the COVID-19 pandemic, the rapid roll-out of a vaccine and the implementation of a worldwide immunization campaign is critical, but its success will depend on the availability of an operational and transparent distribution chain that can be audited by all relevant stakeholders. In this paper, we discuss how blockchain technology can be used for assuring the transparent tracing of COVID-19 vaccine registration, storage and delivery, and side effects self-reporting. We present such system implementation in which blockchain technology is used for assuring data integrity and immutability in case of beneficiary registration for vaccination, eliminating identity thefts and impersonations. Smart contracts are defined to monitor and track the proper vaccine distribution conditions against the safe handling rules defined by vaccine producers enabling the awareness of all network peers. For vaccine administration, a transparent and tamper-proof side effects self-reporting solution is provided considering person identification and administrated vaccine association. A prototype was implemented using the Ethereum test network, Ropsten, considering the COVID-19 vaccine distribution tracking conditions. The results obtained for each on-chain operation can be checked and validated on the Etherscan, demonstrating various aspects of the proposed system such as immunization actors and safe rules registration, vaccine tracking, and administration. In terms of throughput and scalability, the proposed blockchain system shows promising results.

Citations (86)

Summary

No one has generated a summary of this paper yet.

Paper to Video (Beta)

No one has generated a video about this paper yet.

Whiteboard

No one has generated a whiteboard explanation for this paper yet.

Open Problems

We haven't generated a list of open problems mentioned in this paper yet.

Continue Learning

We haven't generated follow-up questions for this paper yet.

Collections

Sign up for free to add this paper to one or more collections.